Outcomes after initial refusal of curative treatment in patients with classic Hodgkin lymphoma

Hodgkin lymphoma (cHL) is considered a highly curable cancer. Treatment extent and duration is primar-ily guided by clinical stage of disease, and long-term survival exceeds 95% for limited-stage and 90% for advanced-stage disease regimens a of patients to or recommended (ABVD) 8 in of

[1]  F. V. van Leeuwen,et al.  Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients , 2020, Journal of the National Cancer Institute.

[2]  E. Taioli,et al.  Disparities in surgery for early-stage cancer: the impact of refusal , 2019, Cancer Causes & Control.

[3]  E. Franco,et al.  Inter- and intraprovincial inequities in public coverage of cancer drug programs across Canada: a plea for the establishment of a pan-Canadian pharmacare program. , 2019, Current oncology.

[4]  J. Beebe-Dimmer,et al.  Race, financial hardship, and limiting care due to cost in a diverse cohort of cancer survivors , 2019, Journal of Cancer Survivorship.

[5]  C. Gross,et al.  Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers , 2018, JAMA oncology.

[6]  R. Gascoyne,et al.  Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD , 2018, Haematologica.

[7]  L. Sehn.  Introduction to a review series on Hodgkin lymphoma: change is here. , 2018, Blood.

[8]  A. Ng,et al.  Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment. , 2016, Hematology. American Society of Hematology. Education Program.

[9]  F. d'Amore,et al.  Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma. , 2016, The New England journal of medicine.

[10]  R. Gascoyne,et al.  Impact of time from diagnosis to initiation of curative-intent chemotherapy on clinical outcomes in patients with classical Hodgkin lymphoma , 2016, Leukemia & lymphoma.

[11]  J. French,et al.  Inequities in access to cancer care in Canada , 2015, Healthcare management forum.

[12]  Ming-Hui Chen,et al.  Refusal of curative radiation therapy and surgery among patients with cancer. , 2014, International journal of radiation oncology, biology, physics.

[13]  R. Gascoyne,et al.  International Prognostic Score in advanced-stage Hodgkin's lymphoma: altered utility in the modern era. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  P. Cleary,et al.  Perceptions of cancer‐related information among cancer survivors: A report from the American Cancer Society's Studies of Cancer Survivors , 2008, Cancer.

[15]  T. Gansler,et al.  A population‐based study of prevalence of complementary methods use by cancer survivors , 2008, Cancer.